Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease

NCT02210741 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02210741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02210741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2014
Completion date
February 29, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graves disease